To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent
Clinical trial NCT00620100 · TERMINATED
Trial details
- NCT number
- NCT00620100
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2005-04-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.